2665.0000 36.00 (1.37%)
NSE Nov 20, 2026 15:31 PM
Volume: 455.9K
 

2665.00
1.37%
Motilal Oswal
Mankind Pharma (MANKIND) delivered better-than-expected 2QFY25 performance, fueled by a strong revival in growth of the consumer business and continued growth momentum in the exports business.
Mankind Pharma Ltd. has an average target of 2871.00 from 4 brokers.
More from Mankind Pharma Ltd.
Recommended